Aims Data concerning the relative risk of amputations in diabetic patients compared with the general population are scarce. Therefore, we carried out a case control study to quantify the relationship between diabetes and amputations.
Introduction
The St Vincent initiative [1] has directed attention to the association of diabetes and the risk of amputations. A reduction of diabetes-related amputations by at least one half within 5 years was declared a primary objective for Europe by the World Health Organization (WHO) and the International Diabetes Federation. However, even worldwide, there is little information about the relative risk of amputations in those with diabetes compared with the general population, and about the risk of amputation attributable to diabetes.
It is possible to estimate relative risks of amputation in the diabetic vs. the non-diabetic population by comparing incidence rates of amputations in diabetic and non-diabetic populations. A recent overview of international studies of the incidence of lower limb amputations [2] demonstrated extreme variability between different populations and a lack of comparability between published studies [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] . In a study in the USA [3] , an age-adjusted relative risk for people with diabetes vs. the general population of 15 was found. This study, although one of the most informative of published studies, is based on discharge data without review of individual patients' records for diabetic status and without the possibility of excluding repeated discharges of the same patient. In a Finnish study, an age-adjusted relative amputation risk of 10.3 for diabetic men, and of 13.9 for diabetic women was found [14] . In a recent study, we estimated relative and attributable risks of amputations due to diabetes on the basis of incidence rates from one German city [17, 18] . When results standardized to the general population were considered, the risk of having an amputation was 22-fold (confidence interval (CI) 11-44) in the diabetic compared with the non-diabetic population. Ninety-five percent (CI 93-97) of the amputation risk in diabetic individuals, and 72% (CI 55-83) of the amputation risk in the entire population were due to diabetes. Those estimates were based on small numbers from a limited area. We do not know whether these results are representative of larger areas. Estimates of incidence rates are not available for bigger populations. Therefore, it was the purpose of this study to estimate the relative risk of amputations in diabetic vs. non-diabetic individuals as well as the risk attributable to diabetes, both in the diabetic individual and in the entire population, based on a larger sample than in our previous study.
We do not know of any case-control studies examining the relationship between diabetes and amputations. No systematic analyses of the risk of amputations attributable to diabetes in more populous regions, both among the exposed and in the entire population, have been published. Some studies reported the proportion of patients with amputations who were known to have diabetes. Such figures may be considered to be only rough approximations of population attributable risk. Information about relative and attributable risks, however, is of great importance to assess the impact of diabetes on the occurrence of amputations and on the use of health care resources. To this end, we carried out a hospital-based case-control study and calculated age-specific and age-adjusted measures.
Subjects and methods
We carried out a case-control study to quantify the relationship between diabetes and amputations. A small subset of the cases had been used previously to calculate incidence rates of amputations in one city [17] .
Definition of cases
Cases were recruited as follows: In 20 hospitals in seven German cities and counties that participated in other studies [17, 19, 20] , we obtained complete lists of non-traumatic lower limb amputations carried out in 1990 and 1991 by extracting operation theatre documentation. The hospitals are located in various areas of the western part of Germany. The inclusion of all hospitals in larger areas was not possible. None of the hospitals had a specialist diabetic foot clinic. Small hospitals where only very few amputations and no controls (due to insufficient electronic data management) could be obtained were excluded from the analysis. All patients who were at least 30 years of age were included. We analysed the hospital records of all patients thus identified. We determined date of operation, amputation level, presence of diabetes, date of birth, address, sex, and-where applicable-whether insulin was taken and duration of diabetes. When more than one amputation was carried out in one patient within the period of observation, only the highest level was counted for the analysis.
Definition of controls
From the hospital administration we obtained complete lists (computer printouts) of all patients treated in the surgical departments from which the cases were recruited during the study period. The printouts contained patient identification, date of birth, sex, dates of admission and discharge, and procedures performed. We drew a random sample of these patients so that sufficient numbers in each cell of the contingency table were obtained (see Table 1 ). (We used the function of the EXCEL software that guaranteed equal probabilities for each patient of the list to be chosen as a control.) Patients below the age of 30 years were excluded. The list of the patients contained in the random sample was reviewed by the epidemiologist responsible for the study (C.T.), and only the patients with procedures not likely to be associated with diabetes were included. This resulted mainly in the exclusion of patients with vascular surgery. The process of collecting information from each patient records, including ascertainment of diabetic status, was identical in the cases and in the controls.
Statistical analysis
The relative risk of amputations for people with diabetes compared with individuals without diabetes was estimated by calculating age-and sex-specific odds ratios (OR i ). To estimate the odds ratio associated with diabetes, adjusted for age and sex, unconditional logistic regression was used [21, 22] . The model contained male sex, the age groups 45-54, 55-64, 65-74, 75-84, and ≥ 85 years, and diabetes as predictor variables. To test for effect modification, i.e. a trend towards decreasing ORs for diabetes with increasing age, and different ORs according to sex, age and sex were included in the model and interaction terms age*diabetes and sex*diabetes were added. In an alternative model, the counties were added as predictor variables. In a further model, smoking was added as a predictor variable. The attributable risk among exposed (ARE i ) in each stratum i was calculated as ARE i = (OR i − 1)/OR i . The age-adjusted attributable risk among exposed (ARE adj ) was calculated as ARE adj = (OR adj − 1)/OR adj . Confidence intervals for the ageand sex-specific ORs were calculated according to Rothman [22] . Confidence intervals for the adjusted ORs are based on the profile likelihood resulting from logistic regression [21] . Confidence limits for ARE i and ARE adj were calculated inserting the upper and lower confidence bounds for OR i or OR adj , respectively. Stratum-specific and age-adjusted population attributable risks (PAR i and PAR adj ), together with confidence limits, were calculated according to the weighted-sum approach as discussed by Benichou [23] . All calculations were carried out with the SAS Statistical package (versions 6.09 and 6.12).
Results
There were 729 cases, of which 486 (66.7%) had diabetes. One hundred and twenty-seven (7.6%) out of 1671 controls had diabetes. The distribution of cases and controls by age, sex and diabetic status is shown in Table 1 . Mean age was 61.7 years ( SD 16.3, median 62, range 30-100). Diabetes duration could be obtained for 414 out of 613 subjects with known diabetes (346 out of 486 cases with diabetes, 68 out of 127 controls with diabetes). Mean diabetes duration was 13.7 years ( SD 10.2, median 11.0, range 0-56.0). Mean diabetes duration of cases was 14.7 years ( SD 10.2, median 13.0, range 0-56.0), of controls 8.5 years ( SD 8.6, median 6.0, range 0-38.0). The distribution with respect to amputation levels is shown in Table 2 . Forty-two patients are known to have also had amputations of the contralateral leg (highest level: nine toe, seven foot, eight lower leg, five knee, 13 thigh).
As expected, there was a high risk of amputations in the diabetic compared with the non-diabetic population in all age groups. In some strata, we found extremely high ORs. The age-and sex-specific results with respect to epidemiological measures (odds ratios and attributable risks) are shown in detail in Table 3 . The attributable risks among exposed were > 90% in all strata except in women > 75 years. The population attributable risk, being a function of both relative risk and prevalence of diabetes, peaked in the age group between 55 and 64 years. In most age groups, even the risk of amputations in the entire population was mainly attributable to diabetes. When adjusted results are considered, 95% (CI 93-96%) of the amputation risk in diabetic individuals, and 62% (CI 57-66%) of the amputation risk in the entire population were due to diabetes.
The result of the logistic regression analysis is shown in 
Discussion
It was possible to quantify the risk of amputations in diabetic vs. non-diabetic individuals using a case-control design. The study was carried out in 20 hospitals in seven towns and counties across former Western Germany. In the hospitals, patients could not be related to an a priori (i.e. geographically) defined population. Consequently, a casecontrol design was appropriate to estimate relative and attributable risks. As was expected, an increased risk of amputation for diabetic individuals was found. The results of this study made it possible to quantify this risk in different sex-and age-specific groups and as an adjusted odds ratio. The difference in mean age between cases and controls was accounted for by a stratified analysis and by a logistic regression analysis. Odds ratios and attributable risks for diabetic individuals are higher in the younger than in the older age groups. It is not surprising that the risk of amputation attributable to diabetes decreased with increasing age, given the higher prevalence of vascular disease in older age groups.
There are some limitations to the design and the results of this study. We had to rely on the information laid down in the records. It is possible that a few diabetic subjects were misclassified as non-diabetic. This would bias the odds ratio towards 1. If the misclassification was higher in the control group than in the cases, the odds ratio might be overestimated. Bias would result if persons with diabetes were more or less prone to become patients in the hospitals included in the study than individuals without diabetes. Although this cannot be excluded, there is no reason to assume that such mechanisms introduced large bias. We included only patients with procedures not likely to be associated with diabetes into the control group, in order to avoid underestimation of the effect of diabetes on amputations due to over-representation of persons with diabetes-related complications among the controls. Although patients with procedures for possibly diabetes-related conditions (mainly vascular diseases) were not eligible for the control group, the proportion of patients with diabetes was still high among the controls. This may indicate that a slight selection bias is possibly still present and that the true effect of diabetes on the amputation risk may still be underestimated. Despite its limitations, the data source used here appears to be more reliable than hospital discharge data used in some studies, for two reasons: diabetic status was ascertained from individual patients' records, and multiple amputations in the same patient could not bias the result towards high-risk groups because we counted patients, not procedures. The present study provides a broader basis for the risk estimates of amputations in relation to diabetes in Germany than our previous study in one German city [17, 18] . Our risk estimates, although slightly lower, are of the same order of magnitude as our risk estimates based on the comparison of incidence rates in one German city, and as those found in an American and a Finnish study [3, 14, 17] . The lower PAR found in a study from Scotland can be explained by an underestimation of the prevalence of diabetes in the UK [24] . However, our study is not based upon a representative sample of German hospitals. The included hospitals are run by cities, counties and the major Christian churches. This is typical of the situation in Germany. University hospitals were not part of the sample. Very small hospitals had to be excluded due to insufficient numbers of patients and difficulties in obtaining the data. Including very large and very small hospitals might alter the risk estimates to some extent. This study shows very high relative amputation risks for people with diabetes and great population attributable risks of this disease. One may assume that improving foot care in people with diabetes should be the main target for the reduction of amputations in the German population. From a public health perspective, great relative and attributable risks in younger age groups indicate the need for increased attention to preventive measures for microvascular complications in younger diabetic individuals, such as tight blood glucose control as well as improved patient education and treatment of the diabetic foot syndrome. Well-designed intervention studies will be needed to demonstrate the effectiveness of particular measures of secondary prevention.
